Doximity Inc Stock Price, News & Analysis

Doximity (NYSE: DOCS) reported strong fiscal 2026 first quarter results with revenue reaching $145.9 million, up 15% year-over-year. The company demonstrated robust profitability with net income of $53.3 million and a 36.5% margin.

Key highlights include operating cash flow of $62.1 million (up 51% YoY) and free cash flow of $60.1 million (up 52% YoY). The company's AI suite showed exceptional growth, increasing 5x year-over-year, while over 630,000 prescribers utilized their workflow tools.

Looking ahead, Doximity projects Q2 FY2026 revenue between $157-158 million and updated its full fiscal year 2026 guidance to $628-636 million in revenue.

Doximity (NYSE:DOCS) has released its 2025 Physician Compensation Report, revealing significant challenges in the healthcare workforce. The study, based on 230,000 survey responses over six years, shows physician compensation grew modestly by 3.7% overall, with a concerning 26% gender pay gap.

Key findings include men's compensation rising 5.7% versus 1.7% for women, significant pay disparities between pediatric subspecialists and adult-medicine counterparts, and surgical specialists earning 87% more than primary care physicians. The report highlights particular strain in pediatric care, with 90% of pediatricians concerned about reimbursement impacts on patient care.

The study also reveals broader workforce challenges, with 85% of physicians reporting being overworked and 77% willing to accept lower pay for better work-life balance.

Doximity (NYSE:DOCS), the leading digital platform for U.S. medical professionals, has scheduled its fiscal 2026 first quarter earnings release for August 7, 2025, after market close. The company will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.

Interested parties can access the live audio webcast through Doximity's Investor Relations page at investors.doximity.com. A replay of the webcast will be made available on the website following the call.

Doximity (NYSE: DOCS), the leading digital platform for U.S. medical professionals, has announced that its co-founder and CEO Jeff Tangney will be presenting at the William Blair 45th Annual Growth Stock Conference. The presentation is scheduled for Tuesday, June 3, 2025, at 4:40 p.m. Central Time.

Doximity (NYSE: DOCS) reported strong Q4 FY2025 financial results with total revenues reaching $138.3 million, up 17% year-over-year. The company demonstrated robust cash flow performance, with Q4 operating cash flow increasing 54% to $98.5 million. For fiscal year 2025, Doximity achieved total revenues of $570.4 million, representing 20% year-over-year growth. Net income margins improved significantly to 45.2% in Q4. The company's subscription revenue grew 17% to $131.9 million in Q4. Looking ahead, Doximity provided Q1 FY2026 guidance with expected revenue between $139-140 million and adjusted EBITDA of $71-72 million. For full FY2026, the company projects revenue of $619-631 million and adjusted EBITDA between $333-345 million.

Doximity (NYSE:DOCS), the leading digital platform for U.S. medical professionals, has scheduled its fiscal 2025 fourth quarter and full year financial results announcement for May 15, 2025, after market close. The company will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the results. Investors can access the live audio webcast through the company's Investor Relations page at https://investors.doximity.com/.

Doximity (NYSE: DOCS), the leading digital platform for U.S. medical professionals, has announced its participation in an upcoming investor event. Anna Bryson, the company's CFO, is scheduled to present at the Raymond James 46th Annual Institutional Investors Conference. The presentation will take place on Tuesday, March 4, 2025, at 10:25 a.m. Eastern Time (7:25 a.m. Pacific Time).

Doximity (NYSE: DOCS) has been named 2025 Best in KLAS in the Video Conferencing Platforms segment for the fourth consecutive year. The company received A-level ratings across all categories, including operations, product, relationship, value, culture, and loyalty, based on interviews with over 80 health system leaders.

Doximity's HIPAA-compliant telehealth platform, Doximity Dialer, enables healthcare providers to connect with patients through phone, video, and text while maintaining personal number privacy. The platform features one-click voice and video visits, custom Caller ID, device and language optimization, and seamless transitions between voice and video calls.

Doximity (NYSE: DOCS) reported strong fiscal Q3 2025 results with total revenue of $168.6 million, up 25% year-over-year. The company demonstrated significant profitability improvements with net income of $75.2 million (57% growth) and adjusted EBITDA of $102.0 million (39% growth).

Key operational highlights include over 610,000 unique providers using clinical workflow tools and AI tools growing 60% quarter-over-quarter. The company's newsfeed reached more than one million unique providers.

For Q4 FY2025, Doximity expects revenue between $132.5-133.5 million and adjusted EBITDA of $62.5-63.5 million. The full fiscal year 2025 guidance was updated to revenue of $564.6-565.6 million and adjusted EBITDA of $306.6-307.6 million.